Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

for
Alzheimer Disease
Location: St Louis MO
Sponsor: Tammie L. S. Benzinger, MD, PhD

Sex: All

Age: 18+

Code: NCT04579120

Recruiting

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

for
HIV/AIDS
Location: Saint Louis MO, Decatur GA, Orlando FL,
Sponsor: Frontier Biotechnologies Inc.

Sex: All

Age: 18+

Code: NCT04560569

Phase 2, Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: St Louis MO, Nashville TN, Maumee OH, Oklahoma City OK,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase 1, Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: St Louis MO, Nashville TN, Durham NC, Houston TX,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase 1, Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: St Louis MO, Detroit MI, Raleigh NC, Houston TX,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: St Louis MO, Decatur IL, Indianapolis IN, Louisville KY,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase 3, Recruiting

Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

for
Non-Arteritic Anterior Ischemic Optic Neuropathy
Location: St Louis MO, Chicago IL, Omaha NE, Grand Rapids MI,
Sponsor: Dompé Farmaceutici S.p.A

Sex: All

Age: 50 - 70+

Code: NCT07453888

Phase 3, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: St Louis MO, Indianapolis IN, Edgewood KY, Milwaukee WI,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: St Louis MO, Jackson TN, Memphis TN, Lenexa KS,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase 3, Recruiting

BoxX-NoAF Clinical Trial

for
Post Operative Atrial Fibrillation,
Location: St Louis MO, Jonesboro AR, Louisville KY, Nashville TN,
Sponsor: AtriCure, Inc.

Sex: All

Age: 65+

Code: NCT06989775

Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: St Louis MO, Kansas City KS, Chicago IL, Columbus OH,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase 3, Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

for
Lupus Nephritis
Location: St Louis MO, Chicago IL, Ann Arbor MI, Atlanta GA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT05201469

Phase 2, Recruiting

Observational PIC Destination Cohort

for
HIV-1-infection
Location: St. Louis MO, Cleveland OH, New York NY,
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Sex: All

Age: 18+

Code: NCT05985642

Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: St Louis MO, Memphis TN, Chicago IL, Columbus OH,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase 1, Phase 2, Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: St Louis MO, Newburgh IN, Kansas City MO,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase 3, Recruiting

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: St Louis MO, Chesterfield MO, Carmel IN, Chicago IL,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase 3, Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase 3, Recruiting

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: St Louis MO, Louisville KY, Denver CO, Nashville TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase 1, Phase 2, Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

for
T-cell NHL (PTCL or CTCL)
Location: St Louis MO, Houston TX, New York NY, Stanford CA
Sponsor: Kyowa Kirin, Inc.

Sex: All

Age: 18+

Code: NCT07192471

Phase 1, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: St Louis MO, Nashville TN, Chicago IL, Milwaukee WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase 3, Recruiting